Brief: XBiotech - European Medicines Agency maintains its May 18, 2017 opinion

XBiotech

15/09/2017 11:10

Sept 15 (Reuters) - XBiotech Inc  XBIT.O  
    * XBiotech - on Sept 14, although there were advancements in 
certain areas of application European Medicines Agency has 
maintained its May 18, 2017 opinion 
    * XBiotech says EMA's opinion maintained following 
re-examination of its Marketing Authorization Application for 
its lead product candidate in EUROPE- SEC filing 
 
Source text for Eikon: [http://bit.ly/2h6RUnU] 
Further company coverage:  XBIT.O  
 
 ((bangalore.newsroom@thomsonreuters.com;))